100 ML zoledronic acid 0.05 MG/ML Injection — RxCUI 705824
RxNorm drug concept · Semantic clinical drug
RxCUI 705824
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI705824
Official name100 ML zoledronic acid 0.05 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aszoledronic acid 5 MG per 100 ML Injection; zoledronic acid 5 MG in 100 ML Injection
FDA products mapped12
Package NDCs mapped13
Reported Medicaid activity (SDUD)4,935 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Zoledronic Acid Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used for osteoporosis, including bone loss from steroids, and for Paget’s disease of bone. It is also used for high blood calcium from cancer and for bone problems from multi...
- A healthcare professional gives it as an IV infusion that takes at least 15 minutes. You do not take it by mouth, so food is not a factor. Your schedule depends on your condition,...
- Fever, muscle aches, headache, joint pain and flu-like symptoms are common. Nausea, vomiting and diarrhea can also happen. Call your doctor if you have severe bone, joint or muscle...
- It can. The drug leaves your body through the kidneys, so kidney function is checked before doses. Staying hydrated helps, and tell us if you take NSAIDs or other drugs that can st...
🕸️ Concept Web — How 100 ML zoledronic acid 0.05 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
100 ML zoledronic acid 0.05 MG/ML Injection
RxCUI 705824 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Zoledronic acid
77655IN
-
Zoledronic acid
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Reclast
705872BN
-
Reclast
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zoledronic acid Injection
1865664SCDF -
Zoledronic acid Injectable Product
1156253SCDG -
Zoledronic acid Injection [Reclast]
1865680SBDF -
Reclast Injectable Product
1178326SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Zoledronic acid Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zoledronic acid 0.05 MG/ML
705823SCDC -
100 ML zoledronic acid 0.05 MG/ML Injection [Reclast]
705875SBD -
Zoledronic acid 0.05 MG/ML [Reclast]
705873SBDC
-
Zoledronic acid 0.05 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zoledronic acid 0.05 MG/ML
SCDC · 705823 -
Zoledronic acid Injection
SCDF · 1865664 -
Zoledronic acid Injectable Product
SCDG · 1156253
Brand-Name Concepts
-
100 ML zoledronic acid 0.05 MG/ML Injection [Reclast]
SBD · 705875 -
Zoledronic acid 0.05 MG/ML [Reclast]
SBDC · 705873 -
Zoledronic acid Injection [Reclast]
SBDF · 1865680 -
Reclast Injectable Product
SBDG · 1178326 -
Reclast
BN · 705872
📦 FDA Products & Package NDCs
12 products · 13 package NDCs
13 package NDCs map to RxCUI 705824 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25021-0830-82 | 1 BAG in 1 CARTON (25021-830-82) / 100 mL in 1 BAG | zoledronic acid | Sagent Pharmaceuticals | 2013-03-02 |
| 25021-0830-87 | 5 BAG in 1 CARTON (25021-830-87) / 100 mL in 1 BAG | zoledronic acid | Sagent Pharmaceuticals | 2025-04-15 |
| 43598-0331-11 | 100 mL in 1 BOTTLE, GLASS (43598-331-11) | Zoledronic Acid | Dr.Reddy's Laboratories Inc | 2013-08-19 |
| 55111-0688-52 | 100 mL in 1 BOTTLE, GLASS (55111-688-52) | Zoledronic Acid | Dr.Reddy's Laboratories Ltd | 2013-04-03 |
| 55150-0283-99 | 1 BOTTLE, GLASS in 1 CARTON (55150-283-99) / 100 mL in 1 BO... | Zoledronic Acid | Eugia US LLC | 2017-12-08 |
| 63323-0966-00 | 1 VIAL, GLASS in 1 CARTON (63323-966-00) / 100 mL in 1 VIAL... | Zoledronic Acid | Fresenius Kabi USA, LLC | 2017-02-17 |
| 66758-0155-46 | 100 mL in 1 BOTTLE (66758-155-46) | Reclast | Sandoz Inc | 2024-12-18 |
| 67457-0619-10 | 1 VIAL in 1 CARTON (67457-619-10) / 100 mL in 1 VIAL | Zoledronic Acid | Mylan Institutional LLC | 2017-05-19 |
| 67457-0794-10 | 1 BAG in 1 POUCH (67457-794-10) / 100 mL in 1 BAG | Zoledronic Acid | Mylan Institutional LLC | 2018-06-05 |
| 68001-0611-33 | 1 BAG in 1 CARTON (68001-611-33) / 100 mL in 1 BAG | Zoledronic acid | BluePoint Laboratories | 2024-07-06 |
| 68083-0135-01 | 1 VIAL, GLASS in 1 CARTON (68083-135-01) / 100 mL in 1 VIAL... | Zoledronic Acid | Gland Pharma Limited | 2016-09-15 |
| 68083-0256-01 | 1 BAG in 1 CARTON (68083-256-01) / 100 mL in 1 BAG | Zoledronic acid | Gland Pharma Limited | 2017-03-13 |
| 71288-0806-51 | 1 BOTTLE, GLASS in 1 CARTON (71288-806-51) / 100 mL in 1 BO... | Zoledronic Acid | Meitheal Pharmaceuticals Inc. | 2023-06-05 |
Observed labelers:
Gland Pharma Limited (2) ·
Mylan Institutional LLC (2) ·
Sagent Pharmaceuticals (2) ·
BluePoint Laboratories (1) ·
Dr.Reddy's Laboratories Inc (1) ·
Dr.Reddy's Laboratories Ltd (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3489 | Zoledronic acid 1mg | 9 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.